Home LiteratureArticle Details
PMID: 11096223 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia.

European neurology ·Vol. 44 ·No. 4 ·2000-00-00 ·Pages 229-35

Wallin A, Sjögren M, Edman A, Blennow K, Regland B

Abstract

The aim was to study the frequently found white-matter changes on computerized tomography (CT) in patients with dementia and to relate these changes to clinical regional brain symptomatology, vascular factors, albumin ratio [indicator of blood-brain barrier (BBB) function] and other CT changes. The study included 85 patients, average age 71 +/- 8, with Alzheimer's disease (n = 56) and vascular dementia (n = 29), who underwent CT (Siemens Somatome DR 1) of the brain. They were inpatients in a psychiatric department specialized in dementia investigations. The degree of CT white-matter changes (absence, mild-moderate, severe) was the basis for the division of the patients into three groups. As the patients without white-matter changes were significantly younger than those with such changes, all statistical analyses were controlled for age. Subcortical symptomatology was significantly more frequent in the group with severe white-matter changes, whereas the reverse was true for parietal symptomatology. Diabetes mellitus, hypertension, ischemic cardiac disease and lacunas were significantly more common in patients with white-matter changes, whereas the frequency of transient ischemic attack/stroke episodes did not differ significantly between the groups. The albumin ratio was significantly higher in the groups with white-matter changes and highest in the group with severe white-matter changes. The findings indicate that white-matter changes in demented patients are at least partially an age- and stroke-independent disease manifestation of the vascular system and is associated with a specific symptom pattern. BBB dysfunction may be the link between the vasculature and the tissue damage.

MeSH Terms
Aged Albumins/cerebrospinal fluid Blood-Brain Barrier/physiology Brain Infarction/etiology,pathology Cerebral Arteries/pathology,physiopathology Cerebrovascular Disorders/complications,pathology,physiopathology Dementia/etiology,pathology,physiopathology Disease Progression Female Humans Male Nerve Fibers, Myelinated/pathology Risk Factors Serum Albumin/metabolism Telencephalon/blood supply,pathology,physiopathology
Chemicals
Albumins Serum Albumin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Wallin A
Institute of Clinical Neuroscience, Göteborg University, Mölndal, Sweden. [email protected]
Sjögren M
Edman A
Blennow K
Regland B
Article Info
Journal
European neurology
Abbr.
Eur Neurol
ISSN
0014-3022
Published
2000-00-00
Pages
229-35
Language
English
Region
Switzerland
NLM ID
0150760
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]